"Surpass(ing)" an era of basal-bolus insulin therapy: tirzepatide vs insulin lispro tid added-on to poorly controlled basal insulin-treated type 2 diabetes

被引：0
|
作者：
Frias, J. P. [1 ]
Rosenstock, J. [2 ]
Rodbard, H. W. [3 ]
Tofe, S. [4 ]
Sears, E. [5 ]
Huh, R. [5 ]
Lando, L. Fernandez [5 ]
Patel, H. [5 ]
机构：
[1] Velocity Clin Res, Los Angeles, CA USA
[2] Velocity Clin Res Med City, Dallas, TX USA
[3] Endocrine & Metab Consultants, Rockville, MD USA
[4] Univ Hosp Son Espases, Palma De Mallorca, Spain
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
6
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] "SURPASS(ing)" an Era of Basal-Bolus Insulin Therapy-Tirzepatide vs. Insulin Lispro TID Added-on to Poorly Controlled Basal Insulin-Treated in Type 2 Diabetes
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee J.
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    DIABETES, 2023, 72
  • [2] Tirzepatide improves health-related quality of life vs insulin lispro in poorly controlled basal insulin-treated adults with type 2 diabetes (SURPASS-6)
    Boye, K.
    Sapin, H.
    Poon, J. -L.
    Lando, L. Fernandez
    Huh, R.
    Wang, M.
    Patel, H.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S314 - S314
  • [3] Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes The SURPASS-6 Randomized Clinical Trial
    Rosenstock, Julio
    Frias, Juan P.
    Rodbard, Helena W.
    Tofe, Santiago
    Sears, Emmalee
    Huh, Ruth
    Lando, Laura Fernandez
    Patel, Hiren
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1631 - 1640
  • [4] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Riccardo Candido
    Kathleen Wyne
    Ester Romoli
    Diabetes Therapy, 2018, 9 : 927 - 949
  • [5] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    DIABETES THERAPY, 2018, 9 (03) : 927 - 949
  • [6] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [7] Tirzepatide Improves HRQoL Compared with Insulin Lispro in Poorly Controlled Basal Insulin-Treated Adults with Long-Standing T2D (SURPASS-6)
    Boye, Kristina
    Sapin, Helene
    Poon, Jiat Ling
    Lando, Laura Fernandez
    Huh, Ruth
    Wang, Mianbo
    Patel, Hiren
    DIABETES, 2023, 72
  • [8] Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes: the SURPASS-6 randomized clinical trial ( vol 330, pg 1631, 2023)
    Rosentock, J.
    Frias, J. P.
    Rodbard, H. W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [9] Optimising basal-bolus therapy in type 2 diabetes: a randomised, controlled trial comparing bolus insulin delivery using an insulin patch vs an insulin pen
    Ramtoola, S.
    Aroda, V. R.
    Bailey, T. S.
    Brazg, R. L.
    Dreon, D. M.
    Frias, J. P.
    Klonoff, D. C.
    Kruger, D. F.
    Levy, B. L.
    Peyrot, M.
    Rosenstock, J.
    Serusclat, P.
    Weinstock, R. S.
    Zraicks, V.
    Bergenstal, R. M.
    DIABETOLOGIA, 2018, 61 : S397 - S397
  • [10] Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
    Shimoda, Seiya
    Okubo, Mina
    Koga, Kotaro
    Sekigami, Taiji
    Kawashima, Junji
    Kukidome, Daisuke
    Igata, Motoyuki
    Ishii, Norio
    Shimakawa, Akiko
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Furukawa, Noboru
    Nishida, Kenro
    Araki, Eiichi
    ENDOCRINE JOURNAL, 2015, 62 (02) : 209 - 216
12345